Irene Cuppari: Whole Blood and Component Therapy in Traumatic Hemorrhage
Irene Cuppari, Director of Transfusion Medicine Service ASST Ovest Milanese, shared Blood Transfusion Journal‘s post on LinkedIn about a recent article she and her colleagues co-authored, published in BT, adding:
“I am pleased to share this Commentary recently published in Blood Transfusion, focused on the use of whole blood in the treatment of traumatic hemorrhage in the prehospital setting.
The recent SWiFT and TOWAR trials represent an important milestone, as they introduce phase 3 randomized evidence in a field that has so far been supported mainly by observational data and physiological rationale.
The message that emerges is clear, though not definitive: whole blood did not demonstrate superiority over component therapy in the prehospital strategies evaluated, but this should not be interpreted as evidence of equivalence or non-inferiority.
A crucial methodological and organizational debate therefore remains open: every transfusion strategy should be assessed not only in terms of clinical effectiveness, but also with regard to sustainability, appropriateness, accessibility, and impact on transfusion services.
Many thanks to my co-authors Daniele Prati, Luca Barcella, and Chiara Novelli for this collaborative work.”
Blood Transfusion Journal shared a post on LinkedIn:
“New Publication Alert
We’ve just published a new article: ‘Prehospital whole blood after SWiFT and TOWAR: not superior, not settled’, focusing on Transfusion Medicine.”
Title: Prehospital whole blood after SWiFT and TOWAR: not superior, not settled
Authors: Daniele Prati, Luca Barcella, Chiara Novelli, Irene Cuppari
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 2, 2026, 18:08Jonathan Penm: Antithrombotic Stewardship Optimizes VTE Prophylaxis in ICU Patients
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE